Assessing glycemic control in patients with diabetes and end-stage renal failure

被引：63

作者：

Ansari, A

Thomas, S

Goldsmith, D ^{[1
]}

机构：

[1] Guys Hosp, Renal Unit, Dept Nephrol & Diabet, London SE1 9RT, England

[2] Kings Coll Hosp London, Dept Diabet, London SE5 9RS, England

来源：

AMERICAN JOURNAL OF KIDNEY DISEASES | 2003年 / 41卷 / 03期

关键词：

diabetes; glucose; metabolic control; dialysis; glycation;

D O I：

10.1053/ajkd.2003.50114

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Blood glucose monitoring is important in optimizing long-term outcomes in diabetic patients. Reliance on near-patient testing and the use of longer term measures of glycation are the current cornerstones. However, as this review details, there are significant problems using blood tests as measures of metabolic control in uremic diabetic patients.

引用

页码：523 / 531

页数：9

共 60 条

[1]

AMIEL SA, 1994, DIAGNOSTIC TESTS END, P187

[2]

Ansari A, 2001, DIABETIC MED, V18, p70A

[3] CLINICAL USEFULNESS OF ESTIMATION OF SERUM FRUCTOSAMINE CONCENTRATION AS A SCREENING-TEST FOR DIABETES-MELLITUS [J].